|
nasdaq:kin
|
3580581
|
Mar 13th, 2022 12:00AM
|
KindredBio
|
5.9K
|
83.00
|
Open
|
Biotechnology
|
Mar 13th, 2022 03:56PM
|
Mar 13th, 2022 03:56PM
|
Kindred Biosciences is a veterinary biopharmaceutical company focused on saving and improving the lives of cats, dogs, and horses. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company's strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for animal companions. The Company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes.
|
Open
|
Recombinant protein therapeutics, veterinary drug development
|
Open
|
1555 Bayshore Highway, Suite #200
|
Burlingame
|
CA
|
US
|
94010
|
|
Kindred Biosciences
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:kin
|
3580581
|
Mar 12th, 2022 12:00AM
|
KindredBio
|
5.9K
|
83.00
|
Open
|
Biotechnology
|
Mar 12th, 2022 10:22AM
|
Mar 12th, 2022 10:22AM
|
Kindred Biosciences is a veterinary biopharmaceutical company focused on saving and improving the lives of cats, dogs, and horses. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company's strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for animal companions. The Company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes.
|
Open
|
Recombinant protein therapeutics, veterinary drug development
|
Open
|
1555 Bayshore Highway, Suite #200
|
Burlingame
|
CA
|
US
|
94010
|
|
Kindred Biosciences
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:kin
|
3580581
|
Mar 11th, 2022 12:00AM
|
KindredBio
|
5.9K
|
83.00
|
Open
|
Biotechnology
|
Mar 11th, 2022 09:01AM
|
Mar 11th, 2022 09:01AM
|
Kindred Biosciences is a veterinary biopharmaceutical company focused on saving and improving the lives of cats, dogs, and horses. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company's strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for animal companions. The Company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes.
|
Open
|
Recombinant protein therapeutics, veterinary drug development
|
Open
|
1555 Bayshore Highway, Suite #200
|
Burlingame
|
CA
|
US
|
94010
|
|
Kindred Biosciences
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:kin
|
3580581
|
Mar 10th, 2022 12:00AM
|
KindredBio
|
5.9K
|
83.00
|
Open
|
Biotechnology
|
Mar 10th, 2022 08:31AM
|
Mar 10th, 2022 08:31AM
|
Kindred Biosciences is a veterinary biopharmaceutical company focused on saving and improving the lives of cats, dogs, and horses. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company's strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for animal companions. The Company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes.
|
Open
|
Recombinant protein therapeutics, veterinary drug development
|
Open
|
1555 Bayshore Highway, Suite #200
|
Burlingame
|
CA
|
US
|
94010
|
|
Kindred Biosciences
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:kin
|
3580581
|
Mar 9th, 2022 12:00AM
|
KindredBio
|
5.9K
|
83.00
|
Open
|
Biotechnology
|
Mar 9th, 2022 10:23AM
|
Mar 9th, 2022 10:23AM
|
Kindred Biosciences is a veterinary biopharmaceutical company focused on saving and improving the lives of cats, dogs, and horses. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company's strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for animal companions. The Company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes.
|
Open
|
Recombinant protein therapeutics, veterinary drug development
|
Open
|
1555 Bayshore Highway, Suite #200
|
Burlingame
|
CA
|
US
|
94010
|
|
Kindred Biosciences
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:kin
|
3580581
|
Mar 8th, 2022 12:00AM
|
KindredBio
|
5.9K
|
83.00
|
Open
|
Biotechnology
|
Mar 8th, 2022 08:42AM
|
Mar 8th, 2022 08:42AM
|
Kindred Biosciences is a veterinary biopharmaceutical company focused on saving and improving the lives of cats, dogs, and horses. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company's strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for animal companions. The Company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes.
|
Open
|
Recombinant protein therapeutics, veterinary drug development
|
Open
|
1555 Bayshore Highway, Suite #200
|
Burlingame
|
CA
|
US
|
94010
|
|
Kindred Biosciences
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:kin
|
3580581
|
Mar 7th, 2022 12:00AM
|
KindredBio
|
5.9K
|
83.00
|
Open
|
Biotechnology
|
Mar 7th, 2022 08:17AM
|
Mar 7th, 2022 08:17AM
|
Kindred Biosciences is a veterinary biopharmaceutical company focused on saving and improving the lives of cats, dogs, and horses. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company's strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for animal companions. The Company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes.
|
Open
|
Recombinant protein therapeutics, veterinary drug development
|
Open
|
1555 Bayshore Highway, Suite #200
|
Burlingame
|
CA
|
US
|
94010
|
|
Kindred Biosciences
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:kin
|
3580581
|
Mar 6th, 2022 12:00AM
|
KindredBio
|
5.9K
|
83.00
|
Open
|
Biotechnology
|
Mar 6th, 2022 03:32PM
|
Mar 6th, 2022 03:32PM
|
Kindred Biosciences is a veterinary biopharmaceutical company focused on saving and improving the lives of cats, dogs, and horses. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company's strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for animal companions. The Company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes.
|
Open
|
Recombinant protein therapeutics, veterinary drug development
|
Open
|
1555 Bayshore Highway, Suite #200
|
Burlingame
|
CA
|
US
|
94010
|
|
Kindred Biosciences
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:kin
|
3580581
|
Mar 5th, 2022 12:00AM
|
KindredBio
|
5.9K
|
83.00
|
Open
|
Biotechnology
|
Mar 5th, 2022 04:24PM
|
Mar 5th, 2022 04:24PM
|
Kindred Biosciences is a veterinary biopharmaceutical company focused on saving and improving the lives of cats, dogs, and horses. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company's strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for animal companions. The Company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes.
|
Open
|
Recombinant protein therapeutics, veterinary drug development
|
Open
|
1555 Bayshore Highway, Suite #200
|
Burlingame
|
CA
|
US
|
94010
|
|
Kindred Biosciences
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:kin
|
3580581
|
Mar 4th, 2022 12:00AM
|
KindredBio
|
5.9K
|
83.00
|
Open
|
Biotechnology
|
Mar 4th, 2022 09:40AM
|
Mar 4th, 2022 09:40AM
|
Kindred Biosciences is a veterinary biopharmaceutical company focused on saving and improving the lives of cats, dogs, and horses. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company's strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for animal companions. The Company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes.
|
Open
|
Recombinant protein therapeutics, veterinary drug development
|
Open
|
1555 Bayshore Highway, Suite #200
|
Burlingame
|
CA
|
US
|
94010
|
|
Kindred Biosciences
|
Health Care
|
Health Care Equipment & Services
|